Facile accelerated specific therapeutic (FAST) platform develops antisense?therapies to counter multidrug-resistant bacteria.
Eller KA, Aunins TR, Courtney CM, Campos JK, Otoupal PB, Erickson KE, Madinger NE, Chatterjee A. Facile accelerated specific therapeutic (FAST) platform develops antisense?therapies to counter multidrug-resistant bacteria. Commun Biol. 2021 03 12; 4(1):331.